Results 171 to 180 of about 118,506 (311)
Efficacy and safety of brodalumab in palmoplantar pustulosis: A 68‐week randomized Phase 3 trial
This open‐label study is a continuation of the 16‐week double‐blind, Phase 3 trial assessing the efficacy and safety of brodalumab 210 mg subcutaneously, till a 68‐week extension period. Continued improvement was seen in the PPPASI 50/75/90 responses, PPPSI scores, PGA 0/1 responses and DLQI. Abstract Background The efficacy and safety of brodalumab in
Masamoto Murakami +6 more
wiley +1 more source
POS0047 THE COMPLEMENT FACTOR H-RELATED PROTEIN-5 EXACERBATES PATHOLOGICAL BONE FORMATION OF ANKYLOSING SPONDYLITIS [PDF]
Chang‐Nam Son +4 more
openalex +1 more source
Medial malleolus triple‐plane osteotomy with autologous iliac bone grafting for the treatment of talar cysts. ABSTRACT Background The geriatric nutritional risk index (GNRI) is a simple index for evaluating malnutrition, but whether it contributes to the development of prosthesis aseptic loosening (PAL) after total joint arthroplasty (TJA) is ...
Jiaxuan Fan +8 more
wiley +1 more source
Orthotic Correction of Postural Unleveling in a Patient With Ankylosing Spondylitis [PDF]
James A. Lipton, Lisa J. Mitchell
openalex +1 more source
Coexisting active pulmonary tuberculosis in tuberculous spondylitis: the prevalence and the role of chest CT [PDF]
Eun Jung Shim +5 more
openalex +1 more source
Analysis of Risk Factors for Postoperative Complications of Thoracolumbar Brucella Spondylitis. [PDF]
Zhang Y, Zhao C, Chen J, Zhang Q.
europepmc +1 more source
A Case of Ankylosing Spondylitis Accompanying Sarcoidosis [PDF]
Byoung Yong Choi +7 more
openalex +1 more source

